JULY 2012 Gene-Related Patents Issued - Full patent | ||||
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,222,005 | Method for gene identification signature (GIS) analysis | Agency for Science, Technology and Research | 17-Jul-12 | Singapore |
8,227,214 | Method for producing an L-amino acid using bacterium of the Enterobacteriaceae family with attenuated expression of a gene coding for small RNA | Ajinomoto Co., Inc. | 24-Jul-12 | Japan |
8,222,007 | L-glutamic acid producing bacterium and a method for producing L-glutamic acid | Ajinomoto Co., Inc. | 17-Jul-12 | Japan |
8,232,059 | Method of identifying A. baumannii with OXA-131-like drug resistance in diabetic patients | Alsultan; Abdulrahman A. | 31-Jul-12 | Saudi Arabia |
8,232,051 | Primer set for gene amplification, reagent for gene amplification including the same, and uses thereof | ARKRAY, Inc. | 31-Jul-12 | Japan |
8,232,081 | Methods and microorganisms for production of panto-compounds | BASF SE | 31-Jul-12 | Germany |
8,221,976 | Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification | Becton, Dickinson and Company | 17-Jul-12 | United States |
8,216,794 | Extracellular serine protease | Board of Trustees of the University of Arkansas | 10-Jul-12 | United States |
8,211,647 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 3-Jul-12 | Japan |
8,232,060 | Gene defects and mutant ALK kinase in human solid tumors | Cell Signaling Technology, Inc. | 31-Jul-12 | United States |
8,211,666 | Sperm-specific cation channel, CATSPER1, and uses therefor | Children's Medical Center Corporation | 3-Jul-12 | United States |
8,216,792 | Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene | Coy; Johannes | 10-Jul-12 | Germany |
8,227,243 | Settings for recombinant adenoviral-based vaccines | Crucell Holland B.V. | 24-Jul-12 | Netherlands |
8,216,844 | Compositions and methods for improved protein production | Danisco US Inc. | 10-Jul-12 | United States |
8,227,200 | Methods for identifying kremen polypeptide binding partners | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | 24-Jul-12 | Germany |
8,211,667 | Fungal promoter for expressing a gene in a fungal cell | DSM IP Assets B.V. | 3-Jul-12 | Netherlands |
8,232,052 | Methods of selecting a dopaminergic neuron proliferative progenitor cells using Lrp4/Corin markers | Eisai R&D Management Co., Ltd. | 31-Jul-12 | Japan |
8,216,785 | Method for detecting neuroblastoma | Fujifilm Corporation | 10-Jul-12 | Japan |
8,232,047 | Luciferase signal enhancing compositions | Gene Stream Pty Ltd. | 31-Jul-12 | Australia |
8,232,053 | EGFR mutations | Genentech, Inc. | 31-Jul-12 | United States |
8,232,062 | EGFR mutations | Genetech, Inc. | 31-Jul-12 | United States |
8,221,991 | Orphan nuclear receptor | GlaxoSmithKline LLC | 17-Jul-12 | United States |
8,216,833 | Cosmid vector | Izumu Saito | 10-Jul-12 | Japan |
8,211,683 | Plasmid, transformants and process for production of 3- carboxymuconolactone | Kabushiki Kaisha Toyota Jidoshokki | 3-Jul-12 | Japan |
8,227,228 | D-amino acid oxidase, and method for production of L-amino acid, 2-oxo acid, or cyclic imine | Kaneka Corporation | 24-Jul-12 | Japan |
8,232,056 | Methods for detecting neovascular age-related macular degeneration | Massachusetts Eye and Ear Infirmary | 31-Jul-12 | United States |
8,216,787 | Biomarker for successful aging without cognitive decline | Medical College of Georgia Research Institute, Inc. | 10-Jul-12 | United States |
8,211,640 | Identification of a family of secreted proteins in vascular endothelium | Millennium Pharmaceuticals, Inc. | 3-Jul-12 | United States |
8,221,979 | Compositions and methods for detecting Noonan syndrome | Mount Sinai School of Medicine | 17-Jul-12 | United States |
8,216,821 | Regulation of heterologous recombinant protein expression in methylotrophic and methanotrophic bacteria | National Research Council of Canada | 10-Jul-12 | Canada |
8,222,004 | Diagnosis and treatment of autism using CD38 | National University Corporation Kanazawa University | 17-Jul-12 | Japan |
8,227,227 | DNase expression in recombinant host cells | Novozymes A/S | 24-Jul-12 | Denmark |
8,216,820 | Transformant of coryneform bacteria capable of producing isopropanol | Research Institute of Innovative Technology for the Earth | 10-Jul-12 | Japan |
8,232,069 | Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes | Sapporo Medical University | 31-Jul-12 | Japan |
8,232,070 | DNP63A gene and screening methods of anticancer agent by using it | Seoul National University Industry Foundation | 31-Jul-12 | Korea |
8,227,249 | Methods and compositions for genomic modification | The Board of Trustees of the Leland Stanford Junior University | 24-Jul-12 | United States |
8,227,186 | Methods and compositions relating to bioluminescent microorganisms | The Ohio State University Research Foundation | 24-Jul-12 | United States |
8,211,645 | Recurrent gene fusions in prostate cancer | The Regents of the University of Michigan | 3-Jul-12 | United States |
8,227,217 | Methods and genetically engineered micro-organisms for the combined production of PDO, BDO and PHP by fermentation | Tsinghua University | 24-Jul-12 | China P. Rep. |
8,211,690 | Modelling in yeast of the mitochondrial ATP6 gene mutations responsible for NARP syndrome in humans and uses thereof for screening for medicaments | Universite Victor Segalen Bordeaux 2 | 3-Jul-12 | France |
8,227,194 | Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32) | University of Maryland, Baltimore | 24-Jul-12 | United States |
8,211,646 | Methods of treating ovarian cancer by modulating SnoN | University of South Florida | 3-Jul-12 | United States |
8,216,781 | Gene polymorphisms as predictors of tumor progression and their use in cancer therapy | University of Southern California | 10-Jul-12 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,229,673 | Human metabolic models and methods | Genomatica, Inc. | 24-Jul-12 | United States |
8,234,077 | Method of selecting genes from gene expression data based on synergistic interactions among the genes | The Trustees of Columbia University in the City of New York | 31-Jul-12 | United States |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,227,516 | Compounds as histone deacetylase inhibitors | 4SC Discovery GmbH | 24-Jul-12 | Germany |
8,221,767 | Antigenicity of infectious pancreatic necrosis virus VP2 sub-viral particles expressed in yeast | Advanced Bionutrition Corporation | 17-Jul-12 | United States |
8,222,222 | Compositions and methods for inhibiting expression of the PCSK9 gene | Alnylam Pharmaceuticals, Inc. | 17-Jul-12 | United States |
8,217,017 | Modulation of insulin like growth factor I receptor expression | Antisense Therapeutics Limited | 10-Jul-12 | Australia |
8,216,998 | Treatment of ischemic events | Biotempt B.V | 10-Jul-12 | Netherlands |
8,216,782 | PTTG1 as a biomarker for cancer treatment | Cedars-Sinai Medical Center | 10-Jul-12 | United States |
8,227,441 | Methods to increase or decrease bone density | Celltech R & D, Inc. | 24-Jul-12 | United States |
8,211,868 | Paramyxovirus vector encoding angiogenesis gene and use thereof | DNAVEC Research Inc. | 3-Jul-12 | Japan |
8,216,586 | Lipases and uses thereof | DSM IP Assets B.V. | 10-Jul-12 | Netherlands |
8,221,770 | Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis | GlaxoSmithKline Biologicals s.a. | 17-Jul-12 | Belgium |
8,227,434 | Materials and methods for treating oncological disorders | H. Lee Moffitt Cancer Center & Research Institute, Inc. | 24-Jul-12 | United States |
8,231,881 | Fusion proteins and their use in the diagnosis and treatment of leishmaniasis | Infectious Disease Research Institute | 31-Jul-12 | United States |
8,227,404 | Method of preventing acute or sub-acute hepatic failure in a subject by administering a soluble human tumor necrosis factor alpha fusion protein | Li; Hai | 24-Jul-12 | China P. Rep. |
8,231,913 | Angina pectoris and ischemic heart disease and synergistic phytoceutical composition for same | Olalde Rangel; Jose Angel | 31-Jul-12 | Venezuera |
8,227,443 | Silencing of CSN5 gene expression using interfering RNA | Protiva Biotherapeutics, Inc. | 24-Jul-12 | Canada |
8,216,564 | Composite oncolytic herpes virus vectors | Ramot At Tel-Aviv University Ltd. | 10-Jul-12 | Israel |
8,227,432 | Transposon system and methods of use | Regents of the University of Minnesota | 24-Jul-12 | United States |
8,222,210 | Methods of using substance P to promote healing of vascular wounds | Reid; Ted | 17-Jul-12 | United States |
8,211,945 | Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient | Seikagaku Corporation | 3-Jul-12 | Japan |
8,222,221 | Modulation of gene expression through endogenous small RNA targeting of gene promoters | The Board of Regents of the University of Texas System | 17-Jul-12 | United States |
8,216,585 | Targeted particles and methods of using the same | The Trustees of the University of Pennsylvania | 10-Jul-12 | United States |
8,231,880 | Simian subfamily C adenoviruses SAdV-40, -31, and -34 and uses thereof | The Trustess of the University of Pennsylvania | 31-Jul-12 | United States |
8,211,422 | Chimeric receptor genes and cells transformed therewith | The United States of America, as represented by the Secretary, Department of Health and Human Services | 3-Jul-12 | United States |
8,211,432 | Treatment of Staphylococcus aureus infections utilizing antibodies that bind to fibronectin binding proteins | University of Manitoba | 3-Jul-12 | Canada |
8,211,423 | Muscle derived cells for the treatment of cardiac pathologies and methods of making and using the same | University of Pittsburgh | 3-Jul-12 | United States |
8,216,573 | Process for the fermentative production of antibodies | Wacker Chemie AG | 10-Jul-12 | Germany |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,217,222 | Methods for identifying markers for early-stage human cancer, cancer progression and recurrence | Anticancer, Inc. | 10-Jul-12 | United States |
8,217,228 | Down-regulation and silencing of allergen genes in transgenic peanut seeds | Dodo; Hortense W. | 10-Jul-12 | United States |
8,212,112 | Gene participating in low temperature germinability in rice and utilization of the same | Hokuren Federation of Agricultural Cooperatives | 3-Jul-12 | Japan |
8,232,453 | Promoter from sweet potato ran GTPase gene for the high level expression in plant-tissue culture and vector using the same | INJE University Industry-Academic Cooperation Foundation | 31-Jul-12 | Korea |
8,227,661 | Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions | Lexicon Genetics, Inc. | 24-Jul-12 | United States |
8,217,227 | Recombinant DNA constructs and methods for controlling gene expression | Monsanto Technology LLC | 10-Jul-12 | United States |
8,232,447 | Animal having modification in MGAT2 gene | MSD K.K. | 31-Jul-12 | Japan |
8,222,487 | Application of ERF genes from Bupleurum kaoi | National Tsing Hua University | 17-Jul-12 | Taiwan |
8,217,226 | Nucleic acids and proteins associated with galactomannan synthesis in coffee | Nestec, S. A. | 10-Jul-12 | Switzerland |
8,222,488 | Enhancing expression of value-added genes by transgenic expression of tombusvirus-based P19 gene mutants | Texas A&M University System | 17-Jul-12 | United States |
8,232,454 | Gene-transfer vector comprising helper-component protease gene of papaya ringspot virus for broad-spectrum virus resistance in crops and use thereof | Yeh; Shyi-Dong | 31-Jul-12 | Taiwan |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,222,370 | Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof | Falini; Brunangelo | 17-Jul-12 | Italy |
8,217,138 | Anti-inflammatory compounds and uses thereof | Yale University | 10-Jul-12 | United States |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,212,017 | Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer | Agensys, Inc. | 3-Jul-12 | United States |
8,217,162 | siRNA targeting interleukin-1 receptor-associated kinase 4(IRAK4) | Dharmacon, Inc. | 10-Jul-12 | United States |
8,222,396 | SiRNA targeting proto-oncogene MET | Dharmacon, Inc. | 17-Jul-12 | United States |
8,222,395 | siRNA targeting kinase insert domain receptor (KDR) | Dharmacon, Inc. | 17-Jul-12 | United States |
8,232,386 | SiRNA targeting apolipoprotein B (APOB) | Dharmacon, Inc. | 31-Jul-12 | United States |
8,232,385 | siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) | Dharmacon, Inc. | 31-Jul-12 | United States |
8,227,185 | Non-M, non-O HIV-1 strains, fragments and uses | Institute National de la Sante et de la Recherche Medical-Inserm | 24-Jul-12 | France |
8,222,386 | P. pastoris ADH promoter and use thereof to direct expression of proteins | Keck Graduate Institute | 17-Jul-12 | United States |
8,232,377 | Method for high-level secretory production of protein | National Institute of Advanced Industrial Science and Technology | 31-Jul-12 | Japan |
8,222,385 | Germ cell marker using fish vasa gene | National University Corporation Tokyo University of Marine Science Technology | 17-Jul-12 | Japan |
8,227,587 | Dengue chimeric viruses | Sanofi Pasteur SA | 24-Jul-12 | France |
8,232,383 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Sirna Therapeutics, Inc. | 31-Jul-12 | United States |
8,232,384 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | University of Western Australia | 31-Jul-12 | Australia |
8,232,381 | Isolated nucleic acid molecules from transgenic papaya line 18-2-4 resistant to papaya ringspot virus and use thereof | Yeh; Shyi-Dong | 31-Jul-12 | Taiwan |
SURGERY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,221,414 | Catheter | Boston Scientific Corporation | 17-Jul-12 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.